Clinical Studies

The following information includes disease specific information. While it is internationally recognized standard practice to provide iron supplementation for numerous disease states, disease specific uses of Proferrin® brand iron supplements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.

Clinical Evaluation of Heme Iron Polypeptide: Sustaining a
Response to rHuEPO in Hemodialysis Patients
Nissenson, et. al., AJKD 2003; 42:325-30

Clinical Studies of HIP: An Oral Heme-Iron Product
Seligman, et. al., Nutritional Research 2000; Vol 20, No 9:1279-1286

Evaluation of the Ability of Heme Iron Polypeptide to Sustain Response to rHuEPO in Peritoneal Dialysis Patients: A Prospective Clinical Evaluation
Ghaddar, et. al., abstract presented at NFK, April 7, 2003, Dallas, TX

*File sizes are large. Please be patient while files are opening.